Skip to main content
Premium Trial:

Request an Annual Quote

Jacob Thaysen, Patrick Kaltenbach, Fred Strohmeier

Agilent Technologies has appointed Jacob Thaysen senior vice president of the company and president of the Diagnostics and Genomics Group, which combines the diagnostics and genomics businesses. Also, Patrick Kaltenbach was named SVP, Agilent, and president of the Life Sciences and Applied Markets Group, which combines the former chemical analysis group and life sciences business. Both appointments took effect immediately.

Fred Strohmeier, who was the president of the life sciences and diagnostics group, is retiring, anticipated to occur in the second quarter of FY 2015. He will serve as an advisor to Agilent until then.

Thaysen was most recently VP and general manager of Agilent’s diagnostics and genomics business within the life sciences and diagnostics group. He joined the company in 2012 after it acquired Dako, where he was corporate VP of R&D. Kaltenbach was Agilent VP and GM of the life sciences products and solutions organization. He previously was at Hewlett-Packard.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.